GlassScriptPhysician profile
Mark A Damante
NPI 1306420955
$2,338.05
in general payments reported to CMS, 2019-2025
12 companies · $776 in 2025
The $776 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $95.40 · 2022: $322 · 2023: $614 · 2024: $530 · 2025: $776.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,920.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,920.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $631.97 | 2023-2025 | Nico Brainpath, Everest Spinal System, Mako |
| Nuvasive, INC. | $486.74 | 2022-2023 | Xlif, Pulse, Modulus |
| Medtronic, INC. | $463.73 | 2021-2025 | Graftonand Grafton Plusdemineralized Bone Matrix (Dbm), Solitaire X, Unid_pass |
| Globus Medical, INC. | $211.75 | 2024 | Excelsius3d Imaging System, Xlif, Colosseum |
| Aesculap, INC. | $207.12 | 2023-2025 | Aesculap, Progav 2.0 |
| Kuros Biosciences USA, INC | $128.85 | 2023 | |
| Arteriocyte Medical Systems, INC. | $88.48 | 2023 | Magellan |
| Integra Lifesciences Corporation | $57.65 | 2025 | Duraseal Exact Spinal Sealant System, Codman Certas, Cusa Clarity |
| Depuy Synthes Sales INC. | $23.75 | 2024 | Teligen |
| Medical Device Business Services, INC. | $17.23 | 2022 | |
| Irras USA, INC. | $15.24 | 2022 | |
| Clearpoint Neuro, INC. | $5.54 | 2024 | Clearpoint |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Damante listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.